Opinion: Outdated Zoning Rules are Hurting the City’s Small Businesses

posted in: News | 0

“As businesses evolve to meet changing consumer preferences, it has become clear that zoning regulations too often put up real, often unnecessary obstacles for businesses looking to make these necessary pivots as a matter of survival.”

Adi Talwar

Small businesses is in Inwood, Manhattan.

CityViews are readers’ opinions, not those of City Limits. Add your voice today!

The world has changed and so too have the ways in which people spend their time and money— but regulations are slow to change, and small businesses are suffering because of it. When New Yorkers spend our money locally, we increasingly do so on goods and services that cannot be purchased online, or on dining out at local restaurants and bars.

As businesses evolve to meet changing consumer preferences, it has become clear that zoning regulations too often put up real, often unnecessary obstacles for businesses looking to make these necessary pivots as a matter of survival. This is why the zoning modifications in the Department of City Planning’s “City of Yes for Economic Opportunity” proposal are so important—many of our regulations were written decades prior to the COVID-19 pandemic and have not been updated for the post-pandemic economy, to support small businesses in the present day.

The impacts of the pandemic on very small businesses (fewer than 10 employees), who make up 89 percent of all New York City businesses, have been particularly challenging. Whether pre-COVID or post-COVID, the fact remains that small local businesses start off with less capital than their national counterparts. JP Morgan Chase found that the median small business pre-COVID held only 27 days cash buffer in reserve, for example, and retail businesses held less: only 19 days’ reserves.

They also often lack the expertise to navigate challenging bureaucracies, resources to hire expeditors, or deep pockets to pay rent while waiting for permits and approvals. Eliminating these hurdles and helping businesses open their doors more quickly will help these entrepreneurs preserve their liquidity and better weather financial shock and irregular cash flows, which in turn saves more small businesses from failing.

New York’s City of Yes for Economic Opportunity proposal, up for a vote at the City Planning Commission next week, includes several key changes that cities across the country should learn from.

One proposal, for example, would streamline today’s time-consuming, expensive, and unnecessary public approval process for neighborhood-serving retail like bodegas. Rather than forcing these businesses to apply for a full rezoning—the same process required to revamp an entire neighborhood’s zoning from manufacturing to residential, as was done in Gowanus, for example—the City of Yes proposal would allow the City Planning Commission to green-light small corner stores through a discretionary authorization.

Another challenge for small businesses in New York comes from today’s relatively narrow definition of what kinds of uses belong on our commercial corridors. In the past, all forms of manufacturing were considered a noxious use that for health and safety reasons needed to be separated from the places where people lived. Today, small scale and artisanal manufacturing co-exist quite well with mixed-use communities—but the zoning code has failed to keep up.

Consider the fact that small bakeries are allowed on commercial strips but must find new spaces if they succeed and grow beyond 750 square feet. And consider bike shops, which are increasingly losing sales to online vendors. Many of these businesses would like to pivot to also offering bike repair, but because of zoning restrictions they cannot. Making it harder, not easier, for businesses to occupy retail spaces unnecessarily elevates our commercial vacancy rates.

New York’s zoning, as with zoning of many other cities, also closely proscribes which types of businesses can locate where—based on definitions that are as much as 60 years old. New York’s zoning code, for instance, specifically names which districts telegraph repair shops can locate in, but not cell phone stores. City of Yes would update these terms and would consolidate minor differences between commercial zoning districts to allow more types of businesses to locate in more places. It is only by expanding the types of businesses that can locate in ground floor spaces that we can create more demand for vacant spaces throughout the city.

As a former New York City Planning Commissioner, I am quite aware of the fact that zoning does not change easily. Yet in this case, it absolutely must.

In my current work advising cities nationwide on this very issue, similar circumstances are causing cities to broaden the definition of what is allowed on the ground floor to include things like makerspaces for local artisans, daycare facilities, breweries, community meeting spaces, and educational and medical uses, among others use—and yes, even housing (which, given many cities’ housing crisis, makes absolute sense!).

Cities across the country are revisiting their zoning codes to ensure that they don’t become unnecessary impediments to ground floor occupancy. New York must do the same and adopt these reforms to become a “City of Yes.”

Larisa Ortiz is the managing director of public non-profit solutions at Streetsense, a global creative consultancy. She is a former member of the New York City Planning Commission and was a Crain’s New York 2023 Notable Leader in Real Estate.

Officials investigate rare nervous system disorder in older adults who got RSV vaccine

posted in: News | 0

By MIKE STOBBE (AP Medical Writer)

NEW YORK (AP) — Health officials are investigating whether there’s a link between two new RSV vaccines and cases of a rare nervous system disorder in older U.S. adults.

The inquiry is based on fewer than two dozen cases seen among more than 9.5 million vaccine recipients, health officials said Thursday. And the available information is too limited to establish whether the shots caused the illnesses, they added.

But the numbers are higher than expected and officials are gathering more information to determine if the vaccines are causing the problem. The data was presented at a meeting of an expert panel that provides vaccine policy advice to the Centers for Disease Control and Prevention.

Officials said they were investigating more than 20 cases of Guillain-Barre syndrome, an rare illness in which a person’s immune system damages nerve cells, causing muscle weakness and paralysis. An estimated 3,000 to 6,000 people develop GBS in the U.S. each year, and it’s more commonly seen in older people, according to the CDC.

Most people fully recover from the syndrome, but some have permanent nerve damage. Guillain-Barre can occur in people after they are infected with a virus, but in some instances cases have been linked to vaccinations.

RSV, or respiratory syncytial virus, is a common cause of cold-like symptoms but it can be dangerous for infants and the elderly.

Last year, the CDC signed off on a recommendation made by the advisory panel, aimed at Americans age 60 and older. It was for a single dose of RSV vaccine. There were two options, one made by Pfizer and the other by GSK.

The CDC said that patients should talk to their doctors about the vaccines and then decide whether to get it.

Officials were aware that instances of Guillain-Barre had been identified in clinical trials done before the shots were approved for sale, and that different systems were watching for signs of problems.

At a meeting of the expert panel on Thursday, CDC officials presented an analysis of the reports taken in by those systems.

About two-thirds of the cases occurred in people who got a version of the vaccine made by Pfizer, called Abrysvo. But officials are also doing follow-up tracking in people who got Arexvy, made by GSK.

About two cases of Guillain-Barre might be seen in every 1 million people who receive a vaccine, health officials estimate. A CDC analysis found the the GSK rate was lower than that, but 4.6 cases per million were reported in recipients of the Pfizer shot.

Data from the U.S. Food and Drug Administration also showed an above-expected number of Guillain-Barre cases being reported in RSV vaccine recipients, with more among Pfizer shot recipients.

“Taken together, these data suggest a potential increased risk” in RSV vaccine recipients 60 and older that must be explored, said Dr. Tom Shimabukuro, a CDC vaccine safety monitoring official.

Officials from GSK and Pfizer made brief statements during the meeting, noting that sorting out a safety signal is complicated.

“Pfizer is committed to the continuous monitoring and evaluation of the safety of Abrysvo” and is conducting four safety studies to look into the possibility of vaccine-related GBS, said Reema Mehta, a Pfizer vice president.

CDC officials also presented estimates that the vaccines have prevented thousands of hospitalizations and hundreds of deaths from RSV, and that current data indicates the benefits of vaccination outweigh the possible risks.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Lionel Laurent: Brain drain from Putin’s Russia is far from over

posted in: Politics | 0

It’s the end of an era for Russia’s best-known tech company, Yandex NV, once hailed as the country’s answer to Alphabet Inc.’s Google and valued at $30 billion before the invasion of Ukraine. This month, it agreed to sell its domestic business for about $5.2 billion, a cut-price level for the Russian tycoons picking it up under the Kremlin’s watch.

Yet the deal also hints at a wartime brain drain of scientific and engineering talent that the West could do more to capture.

Yandex has a controversial reputation: Alexei Navalny, whose death has outraged leaders and prompted protests across Europe, had said the company was responsible for spreading Russian lies. (The European Union agreed, Yandex did not.) Co-founder Arkady Volozh, who now publicly opposes the war, is pushing to be taken off Europe’s sanctions list and says he’s helped “thousands of engineers” leave the country: “They will be an asset wherever they land.”

An estimated 11% to 28% of Russian developers have left the country since the outbreak of war, according to research cited by Science, and fear of more departures is apparently what stopped the Kremlin from nationalizing Yandex outright. While most of the company’s assets and 26,000 staff will stay in Russia, they’ve been separated from a new entity employing about 1,300 people operating abroad in hubs like Finland or Serbia and focused on artificial intelligence.

The pressure is even more acute in the world of scientific research. Russia has lost more than 50,000 researchers in the past five years, according to a senior member of the Russian Academy of Sciences cited by Interfax, as a crackdown on civil society and on wartime dissent takes its toll. Independent publication Novaya Gazeta recently identified at least 270 high-ranking academics who had left since the war began, with half having signed an open letter condemning it.

This is not to ignore Ukraine’s own human scars, with millions of its people having sought refuge in the EU and an estimated 18% of its scientists having left the country, according to a study co-authored by economist Gaetan de Rassenfosse.

There’s an opportunity for Europe and the U.S. to do more to accommodate scientific exiles from both Russia and Ukraine as the war enters its third grueling year, especially if it keeps research going while depriving Vladimir Putin of human capital.

That’s the message I got from two researchers, Oleksandr Gamayun and Mikhail Burtsev — Ukrainian and Russian, respectively — who both work at the London Institute for Mathematical Sciences, a modern-day ivory tower housed in the 18th-century Royal Institution in Mayfair. They’re among recipients of 10 three-year funded positions at the institute for outstanding physicists and mathematicians from Ukraine, Russia and Belarus.

Burtsev, who signed a letter along with other Russian scientists condemning the war, is an expert in AI who left his homeland in September 2022. He praises the freedom to continue doing independent research, and adds that, while the brain drain has had little impact on the war so far, the effect will be “big” over time. Gamayun, a physicist who was in Poland when war broke out, is also happy to have found security and freedom to continue his research — and as for Russian scientists, he says they should be judged “case by case.”

Although 10 fellowships are a nice to have, they are a drop in the ocean compared to the demand out there. “Any initiative should be taken very positively … But I believe that it is not enough,” says Yuri Kovalev, of the Max Planck Institute for Radio Astronomy, who comments that, without more support on the ground, Western boycotts of Russian science risk giving Putin a propaganda boost.

Obviously, this kind of outreach needs to tread carefully. Accommodating exiles shouldn’t turn into an escape clause for those aiding and abetting Russia’s military-industrial complex. And the current high-intensity nature of the fighting means that politicians are more focused on obtaining more bullets rather than more physicists.

But there could be other advantages for host countries in the long run. The parallel with 1930s Germany is instructive: If just one Einstein emerged from the current wave of exiles from Putin’s war, wouldn’t that make it worth it? “Just imagine what would have happened if Britain or the U.S. wouldn’t have hosted German scientists during the Nazi regime,” Joachim Hornegger, president of the FAU, told a conference last year. The U.S. push to profit from these scientists after the war also helped deliver an estimated $10 billion in patents and know-how.

If Yandex’s co-founder is right, Russia’s brain drain isn’t over. If Putin is alive to the threat, maybe the West should be too.

Lionel Laurent is a Bloomberg Opinion columnist writing about the future of money and the future of Europe. Previously, he was a reporter for Reuters and Forbes.

Minnesota 2023 deer harvest down statewide from 2022, DNR says

posted in: News | 0

Minnesota hunters shot 158,678 deer during the 2023 hunting season, a lower total harvest than in recent years, the Department of Natural Resources reported this week. The harvest was down 8% from the 2022 season and 14% lower than the five-year average.

The greatest decreases were in the northern part of the state, where deer harvest compared with 2022 was 21% lower in the northeast region and 8% lower in the northwest region. Other regions saw smaller decreases in harvest, with 3% lower in central and southeast Minnesota, and 4% lower in southern Minnesota.

“In recent years, deer populations have been lower in northern Minnesota, particularly following the severe winters of 2021-2022 and 2022-2023,” Todd Froberg, big game program coordinator with the Minnesota DNR, said in a statement Monday. “Several factors can drive these declines, resulting in fewer deer on the landscape during subsequent hunting seasons.”

Deer numbers can suffer during prolonged severe winters, especially in areas with deep snow or insufficient winter habitat. In these conditions, deer must expend more energy to acquire food, making them more vulnerable to predators.

Wolves play a large role as a predator of deer, especially in winter, but there is little evidence to suggest that northern Minnesota’s low deer numbers are directly due to wolf predation, the DNR said. The influence that wolves play in influencing deer populations likely changes over time and can be exacerbated by other conditions such as poor quality wintering habitat.

Northern Wisconsin and the Upper Peninsula of Michigan, also hit hard by severe winter, saw similar declines in deer harvests in 2023.

“This year’s extremely mild conditions do bode well for deer in northern Minnesota, but deer populations in the far north will need several mild winters to start to recover,” Froberg said.

Crossbows were allowed for all deer hunters for the first time in 2023. Archery hunters killed 24,088 deer which was a similar total compared to 2022. In 2023, crossbows accounted for 43% of the total archery harvest.

“During this first year of crossbows being legal for all hunters, we sold 6% more archery licenses, and youth licenses made up most of that increase,” Froberg said. “Lots of kids who weren’t archery hunting in the past were able to use crossbows and go hunting during the archery season.”

Analysis of the 2023 deer harvest is available in a final deer harvest report. This report and past season harvest reports are available on the Minnesota DNR website at mndnr.gov/mammals/deer/management/statistics.html.

Related Articles

Outdoors |


Good news on business tax revenues boosts Minnesota’s budget surplus to $3.7B

Outdoors |


Widow of fallen Burnsville officer Paul Elmstrand recalls their sweet life together

Outdoors |


Twin Cities sees a swing of 48 degrees as warm air mass bumps into frigid stuff from Canada

Outdoors |


MN Department of Transportation to share state Highway 36 study results

Outdoors |


As police officer spouses prepare 4,000 blue and red roses for memorial service, ‘We’re thinking about them’